Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Implantable matrix having optimum ligand concentrations

Implantable matrix having optimum ligand concentrations

US Patent 11357837 · Granted Jun 14, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Implantable matrix having optimum ligand concentrations2019
Methods and compositions for treating post-operative pain comprising clonidine2017
Compositions and methods for treating post-operative pain using clonidine and bu2017
Clonidine formulations in a biodegradable polymer carrier2017
Fluocinolone formulations in a biodegradable polymer carrier2017
Implantable matrix having optimum ligand concentrations2017
Dexamethasone formulations in a biodegradable material2017
Clonidine formulations in a biodegradable polymer carrier2017
Methods and compositions for treating post-operative pain comprising a local ane2017
Methods and compositions for treating intervertebral disc herniations2016
Methods for treating conditions such as dystonia and post-stroke spasticity with2016
Methods and compositions for treating infections comprising a local anesthetic2016